The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni

1994 ◽  
Vol 16 (10) ◽  
pp. 521-527 ◽  
Author(s):  
A. P. MOUNTFORD ◽  
A. FISHER ◽  
R. A. WILSON
1988 ◽  
Vol 18 (1) ◽  
pp. 123-131 ◽  
Author(s):  
David W. Dunne ◽  
Anna M. Grabowska ◽  
Anthony J. C. Fulford ◽  
Anthony E. Butterworth ◽  
Robert F. Sturrock ◽  
...  

2012 ◽  
Vol 80 (11) ◽  
pp. 3821-3827 ◽  
Author(s):  
Amma A. Semenya ◽  
JoAnn S. Sullivan ◽  
John W. Barnwell ◽  
W. Evan Secor

ABSTRACTMalaria and schistosomiasis are the world's two most important parasitic infections in terms of distribution, morbidity, and mortality. In areas wherePlasmodiumandSchistosomaspecies are both endemic, coinfections are commonplace. Mouse models demonstrate that schistosomiasis worsens a malaria infection; however, just as mice and humans differ greatly, the murine-infectingPlasmodiumspecies differ as much from those that infect humans. Research into human coinfections (Schistosoma haematobium-Plasmodium falciparumversusSchistosoma mansoni-P. falciparum) has produced conflicting results. The rhesus macaque model provides a helpful tool for understanding the role ofS. mansonion malaria parasitemia and antimalarial immune responses usingPlasmodium coatneyi, a malaria species that closely resemblesP. falciparuminfection in humans. Eight rhesus macaques were exposed toS. mansonicercariae. Eight weeks later, these animals plus 8 additional macaques were exposed to malaria either through bites of infected mosquitos or intravenous inoculation. When malaria infection was initiated from mosquito bites, coinfected animals displayed increased malaria parasitemia, decreased hematocrit levels, and suppressed malaria-specific antibody responses compared to those of malaria infection alone. However, macaques infected by intravenous inoculation with erythrocytic-stage parasites did not display these same differences in parasitemia, hematocrit, or antibody responses between the two groups. Use of the macaque model provides information that begins to unravel differences in pathological and immunological outcomes observed between humans withP. falciparumthat are coinfected withS. mansoniorS. haematobium. Our results suggest that migration of malaria parasites through livers harboring schistosome eggs may alter host immune responses and infection outcomes.


2000 ◽  
Vol 96 (4) ◽  
pp. 202-212 ◽  
Author(s):  
A. Kwame Nyame ◽  
Anne M. Leppänen ◽  
Burton J. Bogitsh ◽  
Richard D. Cummings

2020 ◽  
Vol 42 (3) ◽  
Author(s):  
Chiuan Yee Leow ◽  
Charlene Willis ◽  
Candy Chuah ◽  
Chiuan Herng Leow ◽  
Malcolm Jones

2007 ◽  
Vol 14 (4) ◽  
pp. 342-347 ◽  
Author(s):  
Pimmada Jeamwattanalert ◽  
Yuvadee Mahakunkijcharoen ◽  
Leera Kittigul ◽  
Pakpimol Mahannop ◽  
Sathit Pichyangkul ◽  
...  

ABSTRACT Merozoite surface protein 1 (MSP1) is the major protein on the surface of the plasmodial merozoite, and its carboxy terminus, the 19-kDa fragment (MSP119), is highly conserved and effective in induction of a protective immune response against malaria parasite infection in mice and monkeys. However, the duration of the immune response has not been elucidated. As such, we immunized BALB/c mice with a standard four-dose injection of recombinant Plasmodium yoelii MSP119 formulated with Montanide ISA51 and CpG oligodeoxynucleotide (ODN) and monitored the MSP119-specific antibody levels for up to 12 months. The antibody titers persisted constantly over the period of time without significant waning, in contrast to the antibody levels induced by immunization with Freund's adjuvant, where the antibody levels gradually declined to significantly lower levels 12 months after immunization. Investigation of immunoglobulin G (IgG) subclass longevity revealed that only the IgG1 antibody level (Th2 type-driven response) decreased significantly by 6 months, while the IgG2a antibody level (Th1 type-driven response) did not change over the 12 months after immunization, but the boosting effect was seen in the IgG1 antibody responses but not in the IgG2a antibody responses. After challenge infection, all immunized mice survived with negligibly patent parasitemia. These findings suggest that protective immune responses to MSP119 following immunization using oil-based Montanide ISA51 and CpG ODN as an adjuvant are very long-lasting and encourage clinical trials for malaria vaccine development.


2018 ◽  
Vol 40 (12) ◽  
pp. e12591 ◽  
Author(s):  
Moses Egesa ◽  
Lawrence Lubyayi ◽  
Frances M. Jones ◽  
Angela van Diepen ◽  
Iain W. Chalmers ◽  
...  

2007 ◽  
Vol 12 (3) ◽  
pp. 431-444 ◽  
Author(s):  
Kim Vereecken ◽  
Cynthia W. A. Naus ◽  
Katja Polman ◽  
Janet T. Scott ◽  
Mamadou Diop ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document